An observation, real-life trial to assess vildagliptin, vs oral antihyperglycaemics, in combination with oral antihyperglycaemic monotherapy in patients with type 2 diabetes mellitus inqdeuately controlled with one oral antihyperglycaemic.
Phase of Trial: Phase IV
Latest Information Update: 13 Jun 2017
At a glance
- Drugs Vildagliptin (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Acronyms EDGE
- 13 Jun 2017 Results (n=28442)presented at the 77th Annual Scientific Sessions of the American Diabetes Association.
- 23 Nov 2014 New trial record
- 17 Sep 2014 Results of a post-hoc analysis of European patients were presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History